Oscar Health (NYSE:OSCR) Trading Down 5.2% – Here’s What Happened

Oscar Health, Inc. (NYSE:OSCR)’s stock price traded down 5.2% during trading on Friday . The company traded as low as $16.03 and last traded at $16.31. 458,559 shares traded hands during trading, a decline of 86% from the average session volume of 3,191,652 shares. The stock had previously closed at $17.20.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on OSCR shares. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. UBS Group started coverage on Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Oscar Health has an average rating of “Moderate Buy” and a consensus price target of $24.00.

Oscar Health Stock Down 5.9 %

The firm has a market capitalization of $3.84 billion, a price-to-earnings ratio of -40.48, a P/E/G ratio of 31.76 and a beta of 1.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26. The company’s 50 day moving average price is $18.80 and its 200 day moving average price is $18.35.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The business had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.13 billion. During the same quarter in the previous year, the business earned ($0.07) EPS. The company’s quarterly revenue was up 44.6% compared to the same quarter last year. As a group, research analysts forecast that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Alessandrea C. Quane sold 16,793 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the sale, the executive vice president now directly owns 392,607 shares of the company’s stock, valued at $6,697,875.42. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, EVP Alessandrea C. Quane sold 16,793 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $286,488.58. Following the sale, the executive vice president now owns 392,607 shares in the company, valued at $6,697,875.42. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Richard Scott Blackley sold 29,957 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $511,066.42. Following the sale, the chief financial officer now directly owns 853,875 shares in the company, valued at approximately $14,567,107.50. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 169,569 shares of company stock valued at $3,007,069. 25.11% of the stock is owned by insiders.

Institutional Trading of Oscar Health

A number of hedge funds have recently added to or reduced their stakes in the company. Avalon Trust Co acquired a new position in Oscar Health in the 1st quarter worth about $69,000. Point72 Hong Kong Ltd purchased a new stake in shares of Oscar Health in the second quarter valued at approximately $78,000. Quest Partners LLC acquired a new position in shares of Oscar Health during the 2nd quarter worth approximately $93,000. Amalgamated Bank raised its stake in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares during the period. Finally, Optimum Investment Advisors purchased a new position in shares of Oscar Health during the 3rd quarter valued at approximately $142,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.